Exporting Medical Devices to Spain: ÜTS, EUDAMED, CE and Label Language
Two topics set a manufacturer established in Türkiye apart from the rest of the EU when exporting medical devices to Spain: the Spanish label and instructions for use requirement imposed by Real Decreto 192/2023, and AEMPS's marketing register called RECOPS. This page conveys both from the official source; the authorised representative, EUDAMED and ÜTS steps are given with quotations from the legislation.
Representante autorizado: is it needed for Spain
In Spanish legislation the authorised representative appears as representante autorizado, and AEMPS's RPS application is reserved for the registration of authorised representatives established in Spain. A manufacturer established in Türkiye does not enter this register, because it does not have to appoint an authorised representative.
"The ’Union market’ refers to the territories of the European Union Member States, and due to the European Economic Area (EEA) is extended to Norway, Lichtenstein and Iceland, and via the Customs Union Agreement to Turkey."
Source: MDCG 2022-16, Guidance on Authorised Representatives, footnote 1.
The same footnote in the Turkish translation:
"'Union market' refers to the territories of the Member States of the European Union and, owing to the European Economic Area (EEA), is extended to Norway, Liechtenstein and Iceland, and through the Customs Union Agreement to Türkiye."
Source: Turkish translation, MDCG 2022-16 Guidance on Authorised Representatives, footnote 1.
The MDR's authorised representative requirement also covers only a manufacturer not established in a Member State.
"Where the manufacturer of a device is not established in a Member State, the device may only be placed on the Union market if the manufacturer designates a sole authorised representative."
Source: (EU) 2017/745 MDR, Article 11(1).
In the contract with the Spanish distributor, it is stated in a single paragraph that the manufacturer is established in Türkiye, is registered directly in EUDAMED as the manufacturer under the Customs Union, and therefore has no representante autorizado. Thus the representative field stays empty in the RECOPS notification to AEMPS, and this is not considered a deficiency.
Label and instructions for use language: Spanish (castellano)
"Manufacturers shall ensure that the device is accompanied by the information set out in Section 23 of Annex I in an official Union language(s) determined by the Member State in which the device is made available to the user or patient. The particulars on the label shall be indelible, easily legible and clearly comprehensible to the intended user or patient."
Source: Regulation (EU) 2017/745 on Medical Devices (MDR), Article 10(11).
For Spain, the Commission language table refers to Real Decreto 192/2023 of 21 March 2023 (BOE-A-2023-7416). Label and instructions for use in Spanish for both patient and professional users (Article 5.2), implant card in Spanish (Article 36.6), field safety notice in Spanish (Article 35.6). The table has no English flexibility for professional users. This means that a manufacturer in Türkiye prepares a Spanish label and IFU for every device going to Spain; since AEMPS's RECOPS registration also includes uploading the label and instructions for use, the Spanish documents must be ready before registration.
The Turkish label is kept separately for supply in Türkiye; the rule is in the article on Turkish labels and instructions for use. On a multilingual label the UDI carrier is single and must be consistent with the image in ÜTS.
AEMPS and the RECOPS marketing register
The competent authority in Spain is the Agencia Española de Medicamentos y Productos Sanitarios (AEMPS, Madrid). AEMPS's national register page (Registros nacionales de productos RECOPS, RPS; updated 30 July 2026) conveys the following rule: Article 18 of Real Decreto 192/2023 and Article 15 of Real Decreto 942/2025 provide that every economic operator placing a non-custom-made product on the market in Spanish territory is included in AEMPS's marketing register. RECOPS (Registro de comercialización de productos sanitarios) is the electronic application in which economic operators marketing non-custom-made medical devices and IVDs in Spain, and the products they market, are registered, including the start date of marketing, label and instructions for use.
The same page states that the product, manufacturer and certificate information in RECOPS comes from EUDAMED, that notifications made through CCPS and RPS until 27 May 2026 remain for viewing purposes only, and that from then on RPS is used only for custom-made device manufacturers and authorised representatives established in Spain (RD 192/2023 Article 21). The practical path for a manufacturer in Türkiye: first the EUDAMED device registration is completed, then the Spanish distributor makes its own marketing notification in RECOPS by linking it to the EUDAMED data; the label and Spanish IFU are uploaded at this stage. In whose name the registration will be made is determined in the contract.
"Member States may maintain or introduce national provisions on registration of distributors of devices which have been made available on their territory."
Source: Regulation (EU) 2017/745 on Medical Devices (MDR), Article 30(2).
EUDAMED: the data source of RECOPS
Since the AEMPS page clearly states that RECOPS draws manufacturer and device data from EUDAMED, the precondition for selling to Spain is a complete manufacturer and device registration in EUDAMED.
"After having verified the data entered pursuant to paragraph 1, the competent authority shall obtain a single registration number (‘SRN’) from the electronic system referred to in Article 30 and issue it to the manufacturer, the authorised representative or the importer."
Source: (EU) 2017/745 MDR, Article 31(2).
"Before placing a device on the market, other than a custom-made device, the manufacturer shall enter or if, already provided, verify in Eudamed the information referred to in Section 2 of Part A of Annex VI, with the exception of Section 2.2 thereof, and shall thereafter keep the information updated."
Source: (EU) 2017/745 MDR, Article 29(4).
According to the Commission's EUDAMED page, Decision (EU) 2025/2371 was published on 27 November 2025 and the four modules have been mandatory since 28 May 2026; AEMPS's cut-off date of 27 May 2026 coincides with this. The 12-month period for device data:
"no later than 12 months from the date of publication of the notice referred to in Article 34(3) in respect of the electronic system referred to in Article 33(2), points (a) and (b), manufacturers shall ensure that the information to be entered in Eudamed in accordance with Article 29 is entered in that electronic system, including regarding the following devices, provided that those devices are also placed on the market from 6 months from the date of publication of that notice:"
Source: MDR Article 123(3)(e) as amended by Article 1(3)(b) of Regulation (EU) 2024/1860.
The registration steps are in the articles on EUDAMED actor registration, device registration and legacy device registration; for the service, EUDAMED registration consultancy.
ÜTS export notification and free sale certificate for products going to Spain
Individually tracked products leaving for Spain are removed from tracking in ÜTS with the export notification.
"An 'Export Notification' is made for individually tracked products exported by the company."
Source: ÜTS Individual Movement Notifications Guide, Article 17, first paragraph.
"When making an Export Notification in ÜTS, after querying with the product number, lot and/or serial number, entering data in the Customs Declaration number and Quantity fields is mandatory."
Source: ÜTS Individual Movement Notifications Guide, Article 17, second paragraph.
In shipments to Spain by road and sea, several lots can go under a single declaration; the query is made separately for each lot and the same declaration number is entered. The method is in the article on ÜTS individual movement notifications and on the individual notification service page.
A free sale certificate is not a precondition for supply to Spain; the ÜTS Registration Guide defines the certificate as a document issued on request for export.
"Free Sale Certificate: the certificate issued by the Authority, upon the request of the domestic manufacturer or the Türkiye-established EU authorised representative of a foreign manufacturer, in order to export devices within the scope of the Medical Device Regulations, declaring that the relevant devices bearing the CE marking may be marketed in Türkiye and EU member states"
Source: ÜTS Registration Guide TCKKD-KLVZ-03 V4.0 (13.05.2026), Article 4 Definitions (zz).
On request, the application is made from ÜTS following the steps in the free sale certificate article. For a shipment via a free zone or bonded warehouse, see the article on export and bonded warehouse ÜTS registration. The Portugal and Italy pages, which have a similar registration system, are also relevant.
Spain summary table
TopicStatusCompetent authorityAEMPS (Agencia Española de Medicamentos y Productos Sanitarios), MadridLabel / IFU languagePatient and professional user: Spanish (RD 192/2023 Article 5.2); implant card Spanish (Article 36.6)National additional registration / notificationRECOPS marketing register: every economic operator placing a non-custom-made product on the market in Spain (RD 192/2023 Article 18); data is drawn from EUDAMEDIs an AR requiredNo (manufacturer established in Türkiye, Customs Union; MDCG 2022-16 footnote 1)
Medical Device ÜTS Registration Consultancy for exports to Spain
We handle the EUDAMED actor and device registration, ÜTS product registration and export notifications of manufacturers exporting to Spain, and we check that the label and Spanish IFU set required for RECOPS is consistent with the registration data. Request a quote, call +90 505 580 46 22 or send your product list to info@medexmedikal.com.
Frequently Asked Questions
Who makes the RECOPS registration in Spain?
According to the AEMPS page, Article 18 of RD 192/2023 covers every economic operator placing a non-custom-made product on the market in Spain. In practice the Spanish distributor makes its own marketing notification by linking it to the EUDAMED data; the label and Spanish IFU are uploaded to this record. The division of responsibility should be written into the contract.
Do I need to register with RPS?
No. According to AEMPS, after 27 May 2026 the RPS is used only for the registration of custom-made device manufacturers and authorised representatives established in Spain (RD 192/2023 Article 21). Since a manufacturer established in Türkiye has no authorised representative, it does not fall within the scope of the RPS.
Is an English IFU sufficient for exports to Spain?
No. In the Commission language table, the label and instructions for use for Spain appear as Spanish in both the patient and professional user columns (RD 192/2023 Article 5.2).
Can I sell to Spain without EUDAMED device registration?
The AEMPS page states that the product, manufacturer and certificate information in RECOPS comes from EUDAMED; according to the Commission, the UDI/device module has been mandatory since 28 May 2026. Until the EUDAMED registration is completed, the RECOPS notification remains incomplete.
At which stage is the export notification made in ÜTS?
Article 17(2) of the Individual Movement Notifications Guide makes the customs declaration number a mandatory field; the notification is made by lot or serial after the export declaration is closed. A free sale certificate is obtained from ÜTS only if the buyer asks.
